WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Semaglutide (Ozempic, Rybelsus, Wegovy) in Rhode Island

Also known as: Ozempic, Rybelsus, Wegovy

Find doctors, physicians, and healthcare providers who prescribe Semaglutide in Rhode Island. This page lists the top prescribers of Semaglutide based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Semaglutide?

RYBELSUS and OZEMPIC tablets are indicated: • as an additional treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes. • to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal heart attack or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events. It belongs to a class of drugs known as glp-1 receptor agonist.

Total Claims in Rhode Island
18,933
0.3% of all Semaglutide prescriptions nationwide
Total Beneficiaries in Rhode Island
1,972
Total Cost in Rhode Island
$21,919,795

Top Prescribers in RI(0+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Loading more data in background...

Find Semaglutide doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.